These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1851731)

  • 1. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrotizing retinopathy after intraocular inoculation of murine cytomegalovirus in immunosuppressed adult mice.
    Holland GN; Fang EN; Glasgow BJ; Zaragoza AM; Siegel LM; Graves MC; Saxton EH; Foos RY
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2326-34. PubMed ID: 2173685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine cytomegalovirus infection causes apoptosis of uninfected retinal cells.
    Bigger JE; Tanigawa M; Zhang M; Atherton SS
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2248-54. PubMed ID: 10892869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection of retinal neurons during murine cytomegalovirus retinitis.
    Zhang M; Xin H; Roon P; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2047-55. PubMed ID: 15914622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of murine cytomegalovirus to inner ocular structures following disruption of the blood-retina barrier in immunosuppressed BALB/c mice.
    Duan Y; Hernandez R; Pang L; Atherton SS
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):935-40. PubMed ID: 8603879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
    Zhang M; Xin H; Duan Y; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinitis in euthymic mice following inoculation of murine cytomegalovirus (MCMV) via the supraciliary route.
    Atherton SS; Newell CK; Kanter MY; Cousins SW
    Curr Eye Res; 1991 Jul; 10(7):667-77. PubMed ID: 1655355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell depletion increases susceptibility to murine cytomegalovirus retinitis.
    Atherton SS; Newell CK; Kanter MY; Cousins SW
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3353-60. PubMed ID: 1330968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic cytokine immunotherapy for experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency.
    Dix RD; Giedlin M; Cousins SW
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1411-7. PubMed ID: 9191604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha-induced apoptosis in murine cytomegalovirus retinitis.
    Zhou J; Zhang M; Atherton SS
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1691-700. PubMed ID: 17389501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression.
    Gao EK; Yu XH; Lin CP; Zhang H; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2322-7. PubMed ID: 7558728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue.
    Kercher L; Mitchell BM
    J Infect Dis; 2000 Sep; 182(3):652-61. PubMed ID: 10950756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against murine cytomegalovirus retinitis by adoptive transfer of virus-specific CD8+ T cells.
    Bigger JE; Tanigawa M; Thomas CA; Atherton SS
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2608-13. PubMed ID: 10509656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination and replication of MCMV after supraciliary inoculation in immunosuppressed BALB/c mice.
    Duan Y; Ji Z; Atherton SS
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1124-31. PubMed ID: 8125723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of ocular MCMV infection.
    Zinkernagel MS; Petitjean C; Fleming P; Chinnery HR; Constable IJ; McMenamin PG; Degli-Esposti MA
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):369-74. PubMed ID: 19684003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of natural killer cells in murine cytomegalovirus eye infection.
    Inoue Y; Minasi P; Oh JO
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):1954-62. PubMed ID: 8387975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of iNOS facilitates MCMV spread in the retina.
    Zhang M; Zhou J; Marshall B; Xin H; Atherton SS
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):285-92. PubMed ID: 17197545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sindbis virus-induced ocular immunopathology.
    Carreras B; Griffin DE; Silverstein AM
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):571-8. PubMed ID: 6281208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.